Healthcare -
Biotechnology - NASDAQ - US
$ 6.195
-13.2 %
$ 974 M
Market Cap
-4.8
P/E
OCUL - TOTAL CURRENT LIABILITIES
Total Current Liabilities OCUL - Ocular Therapeutix, Inc.
34.9 M
LAST VALUE
15.11%
2 YEAR CAGR
30.67%
5 YEAR CAGR
26.44%
10 YEAR CAGR